Analysts are estimating that Liquidia will report an earnings per share (EPS) of $-0.41.
The market awaits Liquidia's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings History Snapshot
Last quarter the company missed EPS by $0.03, which was followed by a 0.59% drop in the share price the next day.
Here's a look at Liquidia's past performance and the resulting price change:
Quarter
Q1 2025
Q4 2024
Q3 2024
Q2 2024
EPS Estimate
-0.42
-0.40
-0.37
-0.34
EPS Actual
-0.45
-0.46
-0.39
-0.37
Price Change %
-1.0%
3.0%
-2.0%
7.000000000000001%
Liquidia Share Price Analysis
Shares of Liquidia were trading at $20.45 as of August 08. Over the last 52-week period, shares are up 53.27%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Insights Shared by Analysts on Liquidia
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Liquidia.
The consensus rating for Liquidia is Buy, derived from 9 analyst ratings. An average one-year price target of $26.44 implies a potential 29.29% upside.
Comparing Ratings Among Industry Peers
The analysis below examines the analyst ratings and average 1-year price targets of ANI Pharmaceuticals, Harmony Biosciences Hldgs and ...
